|
Volumn 15, Issue 5, 2006, Pages 97-99
|
Intensive lipid lowering with atorvastatin in patients with stable coronary disease
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTILIPEMIC AGENT;
ATORVASTATIN;
CHOLESTEROL;
HIGH DENSITY LIPOPROTEIN;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
LOW DENSITY LIPOPROTEIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
TRIACYLGLYCEROL;
ADULT;
AGED;
ARTICLE;
CEREBROVASCULAR ACCIDENT;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG INDICATION;
DRUG MEGADOSE;
DRUG RESPONSE;
HEART ARREST;
HEART DEATH;
HEART INFARCTION;
HUMAN;
INCIDENCE;
ISCHEMIC HEART DISEASE;
LIPOPROTEIN BLOOD LEVEL;
LOW DRUG DOSE;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
OPEN STUDY;
RANDOMIZED CONTROLLED TRIAL;
RESUSCITATION;
RISK FACTOR;
RISK REDUCTION;
SECONDARY PREVENTION;
TREATMENT OUTCOME;
TRIACYLGLYCEROL BLOOD LEVEL;
|
EID: 33744962115
PISSN: 15568571
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (0)
|